Atlas Trials

Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunate

Clinical trial NCT01523002 · COMPLETED

Trial details

NCT number
NCT01523002
Sponsor
Medicines for Malaria Venture
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria
Start date
2012-01-01
Primary completion
2012-07-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.